Cellular immunity for cancer chemoimmunotherapy—an overview Enrico Mihich Symposium in Writing 26 August 2003 Pages: 661 - 662
Modulation of costimulation to enhance tumor immunity Bridget VesoskyArthur A. Hurwitz Symposium in Writing 15 August 2003 Pages: 663 - 669
Tumor microvasculature as a barrier to antitumor immunity Qing ChenWan-Chao WangSharon S. Evans Symposium in Writing 15 August 2003 Pages: 670 - 679
On combining antineoplastic drugs with tumor vaccines Alicia TerandoJames J. Mulé Symposium in Writing 29 August 2003 Pages: 680 - 685
Combinations of anticancer drugs and immunotherapy Malcolm S. Mitchell Symposium in Writing 26 August 2003 Pages: 686 - 692
l-Ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanoma cells via a caspase-8–independent pathway Jae Seung KangDaeho ChoWang Jae Lee Original Article 24 June 2003 Pages: 693 - 698
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use Françoise Bouet-ToussaintJean-Jacques PatardVéronique Catros-Quemener Original Article 15 July 2003 Pages: 699 - 707
Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma A. P. ValeriM. Pérez-BlasJ. M. Martín-Villa Original Article 26 June 2003 Pages: 708 - 714